Trump suggests Pfizer could win U.S. COVID-19 vaccine approval, JNJ to come later


WASHINGTON, Sept 21 (Reuters) - U.S. President Donald Trump on Monday suggested Pfizer Inc PFE.N could secure the first U.S. approval of a COVID-19 vaccine in coming weeks, saying a contender by Johnson & Johnson JNJ.N could come later.

Asked which drugmaker could be approved, Trump told Fox News in an interview: "Pfizer's doing really well," adding "Johnson & Johnson ... they'll probably be a little later." He also cited efforts by Moderna Inc MRNA.O and AstraZeneca Plc AZN.L.

(Reporting by Susan Heavey)

((; +1 202 843 6600;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.